Opus Genetics (IRD) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 82.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.50% |
| Dec 31, 2025 | -20.84% |
| Sep 30, 2025 | 20.15% |
| Jun 30, 2025 | -61.54% |
| Mar 31, 2025 | 60.95% |
| Dec 31, 2024 | -68.25% |
| Sep 30, 2024 | -34.03% |
| Jun 30, 2024 | -34.29% |
| Mar 31, 2024 | 16.81% |
| Dec 31, 2023 | -19.59% |
| Sep 30, 2023 | 171.34% |
| Jun 30, 2023 | 64.84% |
| Mar 31, 2023 | -134.15% |
| Dec 31, 2022 | 147.50% |
| Sep 30, 2022 | -92.16% |
| Jun 30, 2022 | -57.01% |
| Mar 31, 2022 | -26.35% |
| Dec 31, 2021 | 42.14% |
| Sep 30, 2021 | -58.05% |
| Jun 30, 2021 | 137.08% |
| Mar 31, 2021 | -30.66% |
| Dec 31, 2020 | 185.60% |
| Sep 30, 2020 | 38.39% |
| Jun 30, 2020 | 38.26% |
| Mar 31, 2020 | 36.17% |
| Dec 31, 2019 | -15.86% |
| Sep 30, 2019 | 6.55% |
| Jun 30, 2019 | 34.98% |
| Mar 31, 2019 | -128.45% |
| Dec 31, 2018 | -5.19% |
| Sep 30, 2018 | -30.11% |
| Jun 30, 2018 | -16.65% |
| Mar 31, 2018 | -69.62% |
| Dec 31, 2017 | 28.68% |
| Sep 30, 2017 | 71.00% |
| Jun 30, 2017 | 4.85% |
| Mar 31, 2017 | -27.06% |
| Dec 31, 2016 | -5.84% |
| Sep 30, 2016 | -52.80% |
| Jun 30, 2016 | -6.90% |
| Mar 31, 2016 | 29.79% |
| Dec 31, 2015 | -4.93% |
| Sep 30, 2015 | 61.96% |
| Jun 30, 2015 | -58.56% |
| Mar 31, 2015 | 35.95% |
| Dec 31, 2014 | -15.32% |
| Sep 30, 2014 | -99.56% |
| Jun 30, 2014 | 23.43% |
| Mar 31, 2014 | 37.80% |
| Dec 31, 2013 | 45.71% |
| Sep 30, 2013 | 64.66% |